Brian Rash - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Brian Rash's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists todayBrian Rash
Verified
Editor, Community Impact Newspaper
Texas
Beats
Current affairs
Nagetive impact news
Content
Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer’s disease: a randomized controlled phase 2a trial - Nature Medicine
By Brian Rash Verified, Zarin Zainul, Kevin N. Ramdas| Nature Verified AbstractAlzheimer’s disease (AD) is characterized by progressive cognitive decline, severe brain atrophy and neuroinflammation. We conducted a randomized, double-blind, placebo-controlled, parallel-group phase 2a clinical trial that tested the safety and efficacy of laromestrocel, a bone-marrow-derived, allogeneic mesenchymal stem-cell therapy, in slowing AD clinical progression, atrophy and neuroinflammation.
By Brian Rash Verified| Community Impact Newspaper Verified Food truck A Touch By Tonya-Soul Food & Southern Cuisine will move to 200 E. Pecan St., Pflugerville, on Aug. 14, with a grand opening event Aug. 18. The food truck will join artisan-crafted ice cream food truck Shell We Roll to serve walk-up customers and patrons of local wine bar Three Legged Goat. A Touch By Tonya began operating at 310 E. Pecan St., Pflugerville, on Dec. 1. Prior to that, the food truck had been located at 19903 FM 685, Pflugerville, since May 2022.
Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer’s disease: a randomized controlled phase 2a trial - Nature Medicine
By Brian Rash Verified, Zarin Zainul, Kevin N. Ramdas| Nature Verified AbstractAlzheimer’s disease (AD) is characterized by progressive cognitive decline, severe brain atrophy and neuroinflammation. We conducted a randomized, double-blind, placebo-controlled, parallel-group phase 2a clinical trial that tested the safety and efficacy of laromestrocel, a bone-marrow-derived, allogeneic mesenchymal stem-cell therapy, in slowing AD clinical progression, atrophy and neuroinflammation.
Company Info
Community Impact Newspaper
Community Impact is a privately owned news organization founded by John and Jennifer Garrett. It serves as a prominent source of local news and information, primarily in Texas, covering major metro areas such as Austin, Houston, Dallas, and San Antonio. The company has expanded its operations to include both print and digital products, reflecting its commitment to serving a diverse audience. The organization publishes monthly newspapers that reach approximately 2 million readers, featuring local news, events, and community stories. Community Impact also offers external printing services through its state-of-the-art facility, catering to clients across the U.S. Additionally, the company is developing digital products to complement its print offerings, enhancing the reader experience. Community Impact has partnered with Texas Monthly to include a mini edition of the magazine in its monthly newspapers, further enriching its content. Headquartered in Texas, Community Impact employs around 200 staff members, known as "Impacters," and has established a strong presence in the Texas media landscape. The company has received numerous industry awards and is recognized for its leadership in the evolving news industry.
'+1 512-989-6808
Founded: 2005